News

IB1001 is a recombinant factor IX (FIX) product, which helps prevent bleeding in individuals with hemophilia B. The MAA comprises the data from the clinical program for IB1001,

The program requires ClinicalRM to provide an infrastructure of personnel, materials, equipment, facilities, science, and technology that will sustain an acceptable level of medical research. The Omnibus III

VGX-100 is a human antibody that acts against the human VEGF-C protein and is used to treat glioblastoma and metastatic colorectal cancers. Circadian is also developing VGX-100 for

The Roche Center of Excellence will provide highly potent dosage forms for preclinical, phase 1 and 2 clinical studies. The17,000ft² facility is equipped with specialized equipment which are

Clindamycin treats serious infections caused by susceptible anaerobic bacteria, besides treating infections due to susceptible strains of streptococci, pneumococci, and staphylococci. The latex-free injection which is expected to

Intellect will transfer all of Intellect’s intellectual property rights and data related to OX1 research and development program, to ViroPharma for $6.5m up-front licensing fee. The agreement has

During the course of the study, groups of mice were fed with specially formulated diets containing 5% freeze-dried blueberry powder, 10% blueberry powder or a control diet containing

During the course of the trial, 18 HIV-positive, treatment-naive patients will be treated with the drug for over 10 days. In addition, eight more patients will be given

The PDP is said to be a zero-dollar deductible Part D plan by the company. First Health Value Plus, built on preferred pharmacy networks, offers lower member co-payments